Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services Limited disclosed that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a Drug License. The suspension pertains to one store located at Santrabadi Durg, Chhattisgarh, issued by the Assistant Drugs Controller, Durg District. The Drug License has been suspended for 65 days under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. The order was received on May 5, 2026. The company estimates a potential revenue loss of Rs 16 lakhs due to this suspension.
The impact appears limited as only one store out of the company's network is affected. The estimated revenue loss of Rs 16 lakhs is relatively small and unlikely to have a material impact on the company's overall financial performance.